Skyrizi 180 mg/1.2mL

Skyrizi 180 mg/1.2mL is a subcutaneous injection used for managing moderate to severe plaque psoriasis. This medication, containing risankizumab-rzaa, is designed to help reduce inflammation and improve skin condition.

Skyrizi 180 mg/1.2mL is primarily used for the treatment of moderate to severe plaque psoriasis in adults. This medication works by targeting specific proteins in the body to reduce inflammation and help clear skin lesions. People often ask, 'What is Skyrizi used for?' and the answer is that it is intended for those who have not responded well to other treatments or have severe symptoms.

Common effects of Skyrizi 180 mg/1.2mL may include redness, itching, or swelling at the injection site. Some users might experience fatigue, headache, or upper respiratory infections. These effects vary and are not experienced by everyone.

Skyrizi 180 mg/1.2mL should be handled with care. It is important to follow the instructions provided by your healthcare professional. Store the medication as directed and always check the expiration date before use. Avoid sharing syringes and ensure proper disposal of used needles.

Skyrizi 180 mg/1.2mL may interact with other medications, including those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also interact with this medication.